Task: Translation
Input (Czech): Farmaceutická kompozice, která obsahuje alespon jeden inhibitor lipázy, alespon jeden surfaktant vybraný ze skupiny, kterou tvorí vitamín E(polyethylenglykol 1000)sukcinát (TPGS), poly(oxyethylen)stearáty, poly(oxyethylen)alkylethery, poly(oxyethylen)ricinové oleje, poly(glykolyzované)glyceridy a lecitiny a jejich smesi a alespon jedno dispergacní cinidlo. Tato kompozice se pripravuje smícháním jednotlivých složek a používá se pro výrobu léciv pro prevenci nebo lécení obezity.
Output (English): In the present invention, there is disclosed a pharmaceutical composition comprising at least one lipase inhibitor, at least one surfactant being selected from the group consisting of vitamin E (polyethylene glycol 1000) succinate (TPGS), poly(oxyethylene) stearates, poly(oxyethylene) alkyl ethers, poly(oxyethylene) castor oils, poly(glycolyzed) glycerides, lecithins and mixtures thereof, and at least one dispersant. The pharmaceutical composition of the present invention is prepared by mixing the individual components and is used for the preparation of medicaments intended for prevention or treatment of obesity.